Accendra Health, Inc.ACHNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank0
3Y CAGR-26.3%
5Y CAGR-14.7%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-26.3%/yr
vs -0.7%/yr prior
5Y CAGR
-14.7%/yr
Recent deceleration
Acceleration
-25.6pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$3.26B-61.6%
2024$8.48B+3.3%
2023$8.21B+1.0%
2022$8.13B-1.7%
2021$8.27B+14.9%
2020$7.20B-10.9%
2019$8.08B-3.2%
2018$8.35B+2.5%
2017$8.15B-4.6%
2016$8.54B-